A synthetic peptide homologous to IL-10 functional domain induces monocyte differentiation to TGF-β+ tolerogenic dendritic cells

Immunobiology

Volumn 216, Issue 10, 2011, Pages 1117-1126

  López, Mercedes N ^a,b   Pesce, Bárbara ^a   Kurte, Mónica ^a   Pérez, Claudio ^a,b   Segal, Gabriela ^a   Roa, Johanna ^a   Aguillón, Juan Carlos ^a   Mendoza Naranjo, Ariadna ^a   Gesser, Borbala ^c   Larsen, Christian ^c   Villablanca, Andrea ^a   Choudhury, Aniruddha ^d   Kiessling, Rolf ^d   Salazar Onfray, Flavio ^a  

^a UNIVERSITY OF CHILE   (Chile)

^b HOSPITAL CLÍNICO UNIVERSIDAD DE CHILE   (Chile)

^c AARHUS UNIVERSITY   (Denmark)

^d KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Antigen presentation; Dendritic cells; IL 10; MHC class I; Regulatory T cells; TGF beta

Indexed keywords

GAMMA INTERFERON; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 10; PEPTIDE IT9302; STAT3 PROTEIN; SYNTHETIC PEPTIDE; TRANSCRIPTION FACTOR FOXP3; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ANTIGEN PRESENTATION; ARTICLE; CARBOXY TERMINAL SEQUENCE; CELL DIFFERENTIATION; CELL MATURATION; CELL METABOLISM; CELL STIMULATION; CONTROLLED STUDY; DENDRITIC CELL; DOWN REGULATION; DRUG MECHANISM; ENZYME INACTIVATION; EX VIVO STUDY; HUMAN; HUMAN CELL; IMMUNOMODULATION; IN VITRO STUDY; INHIBITION KINETICS; LEUKOCYTE DIFFERENTIAL COUNT; LYMPHOCYTE PROLIFERATION; MONOCYTE; PHENOTYPE; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN FUNCTION; PROTEIN SYNTHESIS; REGULATORY T LYMPHOCYTE; STRUCTURAL HOMOLOGY; UPREGULATION;

CELL DIFFERENTIATION; DENDRITIC CELLS; HUMANS; IMMUNE TOLERANCE; INTERLEUKIN-10; INTERLEUKIN-12; MONOCYTES; OLIGOPEPTIDES; PEPTIDES; PHAGOCYTOSIS; PHENOTYPE; SIGNAL TRANSDUCTION; T-LYMPHOCYTES; T-LYMPHOCYTES, REGULATORY; TRANSFORMING GROWTH FACTOR BETA;

EID: 80052097089     PISSN: 01712985     EISSN: 18783279     Source Type: Journal    
DOI: 10.1016/j.imbio.2011.04.006     Document Type: Article

References (47)

1. Banchereau J., Steinman R.M. Dendritic cells and the control of immunity. Nature 1998, 392:245-252.
2. Banchereau J., Briere F., Caux C., Davoust J., Lebecque S., Liu Y.J., Pulendran B., Palucka K. Immunobiology of dendritic cells. Annu. Rev. Immunol. 2000, 18:767-811.
3. Brocker T., Riedinger M., Karjalainen K. Targeted expression of major histocompatibility complex (MHC) class II molecules demonstrates that dendritic cells can induce negative but not positive selection of thymocytes in vivo. J. Exp. Med. 1997, 185:541-550.
4. Bros M., Jahrling F., Renzing A., Wiechmann N., Dang N.A., Sutter A., Ross R., Knop J., Sudowe S., Reske-Kunz A.B. A newly established murine immature dendritic cell line can be differentiated into a mature state, but exerts tolerogenic function upon maturation in the presence of glucocorticoid. Blood 2007, 109:3820-3829.
5. Chen W., Jin W., Hardegen N., Lei K.J., Li L., Marinos N., McGrady G., Wahl S.M. Conversion of peripheral CD4+CD25- naive T cells to CD4+CD25+ regulatory T cells by TGF-beta induction of transcription factor Foxp3. J. Exp. Med. 2003, 198:1875-1886.
6. Chorny A., Gonzalez-Rey E., Fernandez-Martin A., Pozo D., Ganea D., Delgado M. Vasoactive intestinal peptide induces regulatory dendritic cells with therapeutic effects on autoimmune disorders. Proc. Natl. Acad. Sci. U.S.A. 2005, 102:13562-13567.
7. Christophe T., Karlsson A., Dugave C., Rabiet M.J., Boulay F., Dahlgren C. The synthetic peptide Trp-Lys-Tyr-Met-Val-Met-NH2 specifically activates neutrophils through FPRL1/lipoxin A4 receptors and is an agonist for the orphan monocyte-expressed chemoattractant receptor FPRL2. J. Biol. Chem. 2001, 276:21585-21593.
8. de Waal-Malefty R., Abrams J., Bennett J., Figdor C., de Vries J. Interleukin 10 (IL-10) inhibits cytokine synthesis by human monocytes: an autoregulatory role of IL-10 produced by monocytes. J. Exp. Med. 1991, 174:1209-1220.
9. Driessler F., Venstrom K., Sabat R., Asadullah K., Schottelius A.J. Molecular mechanisms of interleukin-10-mediated inhibition of NF-kappaB activity: a role for p50. Clin. Exp. Immunol. 2004, 135:64-73.
10. Dumoutier L., Lejeune D., Hor S., Fickenscher H., Renauld J.C. Cloning of a new type II cytokine receptor activating signal transducer and activator of transcription (STAT)1, STAT2 and STAT3. Biochem. J. 2003, 370:391-396.
11. Fiorentino D.F., Zlotnik A., Vieira P., Mosmann T.R., Howard M., Moore K.W., O'Garra A. IL-10 acts on the antigen-presenting cell to inhibit cytokine production by Th1 cells. J. Immunol. 1991, 146:3444-3451.
12. Gesser B., Leffers H., Jinquan T., Vestergaad C., Kirsten N., Sindet-Pedersen S., Lindkaer S., Thestrup-Pedersen K., Gronhoj C. Identification of functional domains on human interleukin 10. Proc. Natl. Acad. Sci. U.S.A. 1997, 94:14620.
13. Ghiringhelli F., Puig P.E., Roux S., Parcellier A., Schmitt E., Solary E., Kroemer G., Martin F., Chauffert B., Zitvogel L. Tumor cells convert immature myeloid dendritic cells into TGF-beta-secreting cells inducing CD4+ CD25+ regulatory T cell proliferation. J. Exp. Med. 2005, 202:919-929.
14. Gonzalez-Rey E., Delgado M. Therapeutic treatment of experimental colitis with regulatory dendritic cells generated with vasoactive intestinal peptide. Gastroenterology 2006, 131:1799-1811.
15. Gregori S., Casorati M., Amuchastegui S., Smiroldo S., Davalli A.M., Adorini L. Regulatory T cells induced by 1 alpha, 25-dihydroxyvitamin D3 and mycophenolate mofetil treatment mediate transplantation tolerance. J. Immunol. 2001, 167(4):1945-1953.
16. Hackstein H., Thomson A.W. Dendritic cells: emerging pharmacological targets of immunosuppressive drugs. Nat. Rev. Immunol. 2004, 4:24-34.
17. Hawiger D., Inaba K., Dorsett Y., Guo M., Mahnke K., Rivera M., Ravetch J.V., Steinman R.M., Nussenzweig M.C. Dendritic cells induce peripheral T cell unresponsiveness under steady state conditions in vivo. J. Exp. Med. 2001, 194:769-779.
18. Hu J.Y., Le Y., Gong W., Dunlop N.M., Gao J.L., Murphy P.M., Wang J.M. Synthetic peptide MMK-1 is a highly specific chemotactic agonist for leukocyte FPRL1. J. Leukoc. Biol. 2001, 70:155-161.
19. Ito S., Ansari P., Sakatsume M., Dickensheets H., Vazquez N., Donnelly R.P., Larner A.C., Finbloom D.S. Interleukin-10 inhibits expression of both interferon alpha- and interferon gamma-induced genes by suppressing tyrosine phosphorylation of STAT1. Blood 1999, 93:1456-1463.
20. Josephson K., Logsdon N.J., Walter M.R. Crystal structure of the IL-10/IL-10R1 complex reveals a shared receptor binding site. Immunity 2001, 15:35-46.
21. Kotenko S.V., Krause C.D., Izotova L.S., Pollack B.P., Wu W., Pestka S. Identification and functional characterization of a second chain of the interleukin-10 receptor complex. EMBO J. 1997, 16:5894-5903.
22. Kurte M., López M., Aguirre A., Escobar A., Aguillón J.C., Charo J., Larsen C., Kiessling R., Salazar-Onfray F. A synthetic peptide homologous to the functional domain of human interleukin 10 downregulates the expression of the MHC class I alpha chain and TAP1/2 in human melanoma cells. J. Immunol. 2004, 173:1731-1737.
23. Levings M.K., Gregori S., Tresoldi E., Cazzaniga S., Bonini C., Roncarolo M.G. Differentiation of Tr1 cells by immature dendritic cells requires IL-10 but not CD25+ CD4+ Tr cells. Blood 2005, 105:1162-1169.
24. Li G., Abediankenari S., Kim Y.J., Campbell T.B., Ito S., Graham-Evans B., Cooper S., Broxmeyer H.E. TGF-beta combined with M-CSF and IL-4 induces generation of immune inhibitory cord blood dendritic cells capable of enhancing cytokine-induced ex vivo expansion of myeloid progenitors. Blood 2007, 110:2872-2879.
25. Liu Y., Wei S.H., Ho A.S., de Waal-Malefyt R., Moore K.W. Expression cloning and characterization of a human IL-10 receptor. J. Immunol. 1994, 152(4):1821-1829.
26. López M.N., Pereda C., Segal G., Muñoz L., Aguilera R., González F.E., Escobar A., Ginesta A., Reyes D., González R., Mendoza-Naranjo A., Larrondo M., Compán A., Ferrada C., Salazar-Onfray F. Prolonged survival of dendritic cell-vaccinated melanoma patients correlates with tumor-specific delayed type IV hypersensitivity response and reduction of tumor growth factor beta-expressing T cells. J. Clin. Oncol. 2009, 27:945-952.
27. Lutz M.B., Schuler G. Immature, semi-mature and fully mature dendritic cells: which signals induce tolerance or immunity?. Trends Immunol. 2002, 23:445-449.
28. McBride J.M., Jung T., de Vries J.E., Aversa G. IL-10 alters DC function via modulation of cell surface molecules resulting in impaired T-cell responses. Cell. Immunol. 2002, 215:162-172.
29. Menges M., Rossner S., Voigtlander C., Schindler H., Kukutsch N.A., Bogdan C., Erb K., Schuler G., Lutz M.B. Repetitive injections of dendritic cells matured with tumor necrosis factor a induce antigen-specific protection of mice from autoimmunity. J. Exp. Med. 2002, 195:15-21.
30. Pestka S., Krause C.D., Sarkar D., Walter M.R., Shi Y., Fisher P.B. Interleukin-10 and related cytokines and receptors. Annu. Rev. Immunol. Rev. 2004, 22:929-979.
31. Popov I., Li M., Zheng X., San H., Zhang X., Ichim T.E., Suzuki M., Feng B., Vladau C., Zhong R., Garcia B., Strejan G., Inman R.D., Min W.P. Preventing autoimmune arthritis using antigen-specific immature dendritic cells: a novel tolerogenic vaccine. Arthritis Res. Ther. 2006, 8(5):R141.
32. Pyzik M., Piccirillo C.A. TGF-beta1 modulates Foxp3 expression and regulatory activity in distinct CD4+ T cell subsets. J. Leukoc. Biol. 2007, 82:335-346.
33. Rutella S., Danese S., Leone G. Tolerogenic dendritic cells: cytokine modulation comes of age. Blood 2006, 108:1435-1440.
34. Salazar-Onfray F. Interleukin-10: a cytokine used by tumors to escape immunosurveillance. Med. Oncol. 1999, 16:86-94.
35. Salazar-Onfray F., Charo J., Petersson M., Freland S., Noffz G., Qin Z., Blankenstein T., Ljunggren H.-G., Kiessling R. Down-regulation of the expression and function of TAP in murine tumor cell lines expressing Interleukin-10. J. Immunol. 1997, 159:3195-3202.
36. Salazar-Onfray F., López M.N., Mendoza-Naranjo A. Paradoxical effects of cytokines in tumor immune surveillance and tumor immune escape. Cytokine Growth Factor Rev. 2007, 18:171-182.
37. Salazar-Onfray F., Petersson M., Franksson L., Matsuda M., Blankenstein T., Kärre K., Kiessling R. IL-10 converts mouse lymphoma cells to a CTL-resistant NK sensitive phenotype with low but peptide-inducible MHC class I expression. J. Immunol. 1995, 154:6291-6298.
38. Salazar L., Aravena O., Abello P., Escobar A., Contreras-Levicoy J., Rojas-Colonelli N., Catalán D., Aguirre A., Zúñiga R., Pesce B., González C., Cepeda R., Cuchacovich M., Molina M.C., Salazar-Onfray F., Delgado M., Toes R.E., Aguillón J.C. Modulation of established murine collagen-induced arthritis by a single inoculation of short-term lipopolysaccharide-stimulated dendritic cells. Ann. Rheum. Dis. 2008, 67:1235-1241.
39. Schottelius A.J., Mayo M.W., Sartor R.B., Baldwin A.S. Interleukin-10 signaling blocks inhibitor of kappaB kinase activity and nuclear factor kappaB DNA binding. J. Biol. Chem. 1999, 274:31868-31874.
40. Sebald W., Nickel J., Zhang J.L., Mueller T.D. Molecular basis of cytokine signalling-theme and variations. FEBS J. 2010, 277:106-118.
41. Steinbrink K., Wolfl M., Jonuleit H., Knop J., Enk A.H. Induction of tolerance by IL-10-treated dendritic cells. J. Immunol. 1997, 159:4772-4780.
42. Steinman R.M. Dendritic cells: understanding immunogenicity. Eur. J. Immunol. Rev. 2007, 37:53-60.
43. Steinman R.M., Hawiger D., Nussenzweig M.C. Tolerogenic dendritic cells. Ann. Rev. Immunol. 2003, 21:685-711.
44. van Duivenvoorde L.M., Louis-Plence P., Apparailly F., van der Voort E.I., Huizinga T.W., Jorgensen C., Toes R.E. Antigen-specific immunomodulation of collagen-induced arthritis with tumor necrosis factor-stimulated dendritic cells. Arthritis Rheum. 2004, 50:3354-3364.
45. Williams L., Bradley L., Smith A., Foxwell B. Signal transducer and activator of transcription 3 is the dominant mediator of the anti-inflammatory effects of IL-10 in human macrophages. J. Immunol. 2004, 172:567-576.
46. Yamazaki S., Patel M., Harper A., Bonito A., Fukuyama H., Pack M., Tarbell K.V., Talmor M., Ravetch J.V., Inaba K., Steinman R.M. Effective expansion of alloantigen-specific Foxp3+ CD25+ CD4+ regulatory T cells by dendritic cells during the mixed leukocyte reaction. Proc. Natl. Acad. Sci. U.S.A. 2006, 103:2758-2763.
47. Yamazaki S., Iyoda T., Tarbell K., Olson K., Velinzon K., Inaba K., Steinman R.M. Direct expansion of functional CD25+ CD4+ regulatory T cells by antigen-processing dendritic cells. J. Exp. Med. 2003, 198:235-247.